Corcept Therapeutics (CORT)

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

的Corcept Therapeutics Incorporated Common Stock（CORT）股票的价格今天是$35.25，自市场开启。该公司市值为$37.50亿，日交易量为$57.06万股。对于关注价格走势的投资者来说，Corcept Therapeutics Incorporated Common Stock股票今日的波动区间在$34.00和$35.25之间。前一交易日收盘价为 $35.96。

您准备好开始了吗？按照以下步骤操作，或阅读我们关于在Kraken上从10美元起购买Corcept Therapeutics股票的指南。